Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000064

EVP, Chf Clinical Develop Ofcr sold 6,523 shares at $32.79 ($213,889)

  • EVP, Chf Clinical Develop Ofcr acquired 17,372 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-01-15 Exercise or conversion : show line 1 in the form +17,372 65,031 D
2025-01-16 Sale : show line 2 in the form −6,523 $32.79 $213,889 58,508 D
Open-market sales · 6,523 sh · avg $32.79 · $213,889

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-01-15 Grant or award : show line 3 in the form Performance Restricted Stock Units +22,000 65,437 D
2025-01-15 Grant or award : show line 4 in the form Restricted Stock Unit +33,000 78,308 D
2025-01-15 Exercise or conversion : show line 5 in the form Restricted Stock Unit −17,372 60,936 D
Loading xslF345X05/edgardoc.xml…